Cargando…
Clinical implications of genomic evaluations for prostate cancer risk stratification, screening, and treatment: a narrative review
New classification systems based on molecular features have been introduced to improve precision medicine for prostate cancer (PCa). This review covers the increasing risk of PCa and the differences in response to targeted therapy that are related to specific gene variations. We believe that genomic...
Autores principales: | Chung, Jae-Seung, Morgan, Todd M., Hong, Sung Kyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Pacific Prostate Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557186/ https://www.ncbi.nlm.nih.gov/pubmed/33102389 http://dx.doi.org/10.1016/j.prnil.2020.09.001 |
Ejemplares similares
-
Left Ventricular Apical Aneurysm in Fabry Disease: Implications for Clinical Significance and Risk Stratification
por: Chang, Hao‐Chih, et al.
Publicado: (2022) -
Novel concepts for risk stratification in prostate cancer
por: Patel, Keval M, et al.
Publicado: (2016) -
Biomarkers for prostate cancer detection and risk
stratification
por: Farha, Mark W., et al.
Publicado: (2022) -
Risk Stratification of Childhood Medulloblastoma Using Integrated Diagnosis: Discrepancies with Clinical Risk Stratification
por: Cho, Hee Won, et al.
Publicado: (2022) -
On Risk Estimation versus Risk Stratification in Early Prostate Cancer
por: Carlsson, Sigrid V., et al.
Publicado: (2016)